Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00352742
Status:
TERMINATED
Last Update Posted:
2008-10-28
First Post:
2006-07-13
Brief Title:
A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma
Sponsor:
Attenuon
Organization:
Attenuon
Organization Data
Organization:
Attenuon
Class:
INDUSTRY
Study ID:
ATN-224-007
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Attenuon
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jennifer Callahan Senior Manager Clinical Development
Old Organization:
Attenuon LLC